Companies
- Companies
- Browse
Companies
CrystecPharma applies the latest supercritical fluid (SCF) technologies to improve the design and performance of medicines More
Darier Laboratories is a vertically integrated specialty pharmaceutical company that develops, manufactures, markets, and sells therapies and technologies exclusively in dermatology. More
The Pierre Fabre Group, the second-largest independent laboratory in France, employs about 9,300 people and achieved sales of 1.47 billion euros in 2004. More
Orivas markets and sells branded prescription and OTC medicines in Women's health care, Dermatology, Oncology More
CollaGenex is developing dermatological applications of its proprietary IMPACS™ technology. Oracea™ (doxyxcycline, USP) 40 mg* was approved by the FDA on May 26, 2006. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jun 2006 - 434 pages - $2,495
Jul 2011 - 96 pages - $3,835
Dec 2007 - 49 pages - $495
Nov 2009 - 142 pages - $2,350
Feb 2006 - 332 pages - $3,900
Jan 2008 - 330 pages - $4,200
Oct 2011 - 89 pages - $3,500
Nov 2010 - 189 pages - $2,350
Jan 2010 - 250 pages - $3,900
Jan 2010 - $75
Your selection
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us